• 1
    Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122: 521529.
  • 2
    Fallon M, Abrams G. Pulmonary dysfunction in chronic liver disease. HEPATOLOGY 2000; 32: 859865.
  • 3
    Schenk P, Schoniger-Hekele M, Furhmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 10421052.
  • 4
    Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. HEPATOLOGY 2005; 41: 11221129.
  • 5
    Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, on behalf of the ERS Task Force Pulmonary-Hepatic Vascular Disorders Scientific Committee ERS Task Force PHD Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24: 861880.
  • 6
    Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax 1982; 37: 840844.
  • 7
    Bradley TD, Phillipson EA. Sleep disorders. In: MurrayJF, NadelJA, MasonRJ, et al, eds. Textbook of Respiratory Medicine. Philadelphia, PA: WB Saunders; 2000.
  • 8
    Millman RP, Kramer NR. Sleep disorders and outpatient treatment of patients with pulmonary disease. Curr Opin Pulm Med 1996; 2: 507512.
  • 9
    Rafanan AL, Golish JA, Dinner DS, Hague LK, Arroliga AC. Nocturnal hypoxemia is common in primary pulmonary hypertension. Chest 2001; 120: 894899.
  • 10
    Javaheri S, Almoosa KF, Saleh K, Mendenhall CL. Hypocapnia is not a predictor of central sleep apnea in patients with cirrhosis. Am J Resp Crit Care Med 2005; 171: 908911.
  • 11
    Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485491.
  • 12
    Pauwels R, Buist A, Ma P, Jenkins C, Hurd S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Repir Care 2001; 46: 798825.
  • 13
    Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97: 11651170.
  • 14
    Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force. Standardization of spirometry. Eur Respir J 2005; 26: 319338.
  • 15
    Anthonisen NR, Fleetham JA. Ventilation: total, alveolar, and dead space. In: FarhiLE, TenneySM, eds. Handbook of Physiology. Vol. 4. The Respiratory System. Bethesda, MD: American Physiological Society; 1987: 113129.
  • 16
    Pratt-Ubanama MN, Nishizaka MK, Boedefeld RK, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131: 453459.
  • 17
    Rechtshaffen A, Kales A. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. Los Angeles, CA: Brain Information Service, UCLA; 1968.
  • 18
    Available at:
  • 19
    Yilmaz, H, Iskensen I. Follow-up with objective and subjective tests of the sleep characteristics of patients after cardiac surgery. Circ J 2007; 71: 15061510.